Latest Insider Transactions at Bristol Myers Squibb CO (BMY)
This section provides a real-time view of insider transactions for Bristol Myers Squibb CO (BMY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRISTOL MYERS SQUIBB CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRISTOL MYERS SQUIBB CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
SELL
Payment of exercise price or tax liability
|
Direct |
7,860
-2.2%
|
$448,020
$57.93 P/Share
|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
BUY
Other acquisition or disposition
|
Direct |
1,835
+0.85%
|
-
|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
BUY
Exercise of conversion of derivative security
|
Direct |
18,407
+4.83%
|
-
|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
SELL
Other acquisition or disposition
|
Direct |
102
-0.08%
|
-
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
28,312
-0.98%
|
$1,613,784
$57.93 P/Share
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
BUY
Other acquisition or disposition
|
Direct |
5,096
+0.29%
|
-
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
51,598
+1.74%
|
-
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
SELL
Other acquisition or disposition
|
Direct |
298
-0.03%
|
-
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
14,462
-5.89%
|
$824,334
$57.93 P/Share
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
BUY
Other acquisition or disposition
|
Direct |
3,093
+2.0%
|
-
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
31,169
+10.91%
|
-
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
SELL
Other acquisition or disposition
|
Direct |
174
-0.23%
|
-
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,017
-6.66%
|
$114,969
$57.93 P/Share
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Other acquisition or disposition
|
Direct |
552
+2.78%
|
-
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+14.29%
|
-
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Other acquisition or disposition
|
Direct |
39
-0.43%
|
-
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Payment of exercise price or tax liability
|
Direct |
13,540
-5.42%
|
$771,780
$57.93 P/Share
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Other acquisition or disposition
|
Direct |
3,019
+1.95%
|
-
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Exercise of conversion of derivative security
|
Direct |
30,519
+10.77%
|
-
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Other acquisition or disposition
|
Direct |
184
-0.24%
|
-
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,738
-1.45%
|
$612,066
$57.93 P/Share
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Other acquisition or disposition
|
Direct |
2,030
+0.45%
|
-
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,806
+2.7%
|
-
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Other acquisition or disposition
|
Direct |
124
-0.04%
|
-
|
|
Mar 04
2020
|
John E Elicker EVP, Investor Relations |
SELL
Open market or private sale
|
Direct |
15,805
-21.22%
|
$964,105
$61.01 P/Share
|
|
Mar 02
2020
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
84,308
-63.56%
|
$5,058,480
$60.59 P/Share
|
|
Mar 02
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
93,468
+14.46%
|
$4,486,464
$48.03 P/Share
|
|
Mar 01
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
8,473
-25.65%
|
$499,907
$59.06 P/Share
|
|
Mar 01
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
17,204
+34.25%
|
-
|
|
Mar 01
2020
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,470
-23.39%
|
$617,730
$59.06 P/Share
|
|
Mar 01
2020
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,579
+35.44%
|
-
|
|
Mar 01
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
8,923
-18.55%
|
$526,457
$59.06 P/Share
|
|
Mar 01
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
23,349
+32.68%
|
-
|
|
Feb 04
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,071
-6.34%
|
$68,544
$64.29 P/Share
|
|
Feb 04
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
2,076
+10.94%
|
-
|
|
Feb 04
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-4.49%
|
$74,432
$64.29 P/Share
|
|
Feb 04
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
3,592
+12.17%
|
-
|
|
Dec 31
2019
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,094
-23.19%
|
$390,016
$64.19 P/Share
|
|
Dec 31
2019
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,373
+32.01%
|
-
|
|
Dec 31
2019
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
7,910
-25.7%
|
$506,240
$64.19 P/Share
|
|
Dec 31
2019
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
16,060
+34.29%
|
-
|
|
Dec 05
2019
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
1,740
-9.95%
|
$100,920
$58.81 P/Share
|
|
Dec 04
2019
|
Michael W Bonney Director |
BUY
Open market or private purchase
|
Direct |
88
+1.21%
|
$5,104
$58.9 P/Share
|
|
Dec 01
2019
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
968
-19.38%
|
$54,208
$56.94 P/Share
|
|
Dec 01
2019
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,825
+36.13%
|
-
|
|
Nov 20
2019
|
Nadim Ahmed EVP and President, Hematology |
BUY
Grant, award, or other acquisition
|
Indirect |
1,966
+50.0%
|
-
|
|
Nov 20
2019
|
Nadim Ahmed EVP and President, Hematology |
BUY
Grant, award, or other acquisition
|
Direct |
14,819
+50.0%
|
-
|
|
Nov 20
2019
|
Rupert Vessey EVP & President, Research |
BUY
Grant, award, or other acquisition
|
Indirect |
613
+50.0%
|
-
|
|
Nov 20
2019
|
Rupert Vessey EVP & President, Research |
BUY
Grant, award, or other acquisition
|
Direct |
14,178
+50.0%
|
-
|
|
Nov 20
2019
|
David V Elkins EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
195
+50.0%
|
-
|